Journal Article

DKFZ-2024-01095

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Deep learning for dual detection of microsatellite instability and POLE mutations in colorectal cancer histopathology.

Gustav, M. ; Reitsam, N. G. ; Carrero, Z. I. ; Loeffler, C. M. L. ; van Treeck, M. ; Yuan, T.DKFZ* ; West, N. P. ; Quirke, P. ; Brinker, T.DKFZ* ; Brenner, H.DKFZ* ; Favre, L. ; Märkl, B. ; Stenzinger, A. ; Brobeil, A. ; Hoffmeister, M. ; Calderaro, J. ; Pujals, A. ; Kather, J. N.

2024
Springer Nature [London]

This record in other databases:  

Please use a persistent id in citations: doi:10.1038/s41698-024-00592-z

Abstract: In the spectrum of colorectal tumors, microsatellite-stable (MSS) tumors with DNA polymerase ε (POLE) mutations exhibit a hypermutated profile, holding the potential to respond to immunotherapy similarly to their microsatellite-instable (MSI) counterparts. Yet, due to their rarity and the associated testing costs, systematic screening for these mutations is not commonly pursued. Notably, the histopathological phenotype resulting from POLE mutations is theorized to resemble that of MSI. This resemblance not only could facilitate their detection by a transformer-based Deep Learning (DL) system trained on MSI pathology slides, but also indicates the possibility for MSS patients with POLE mutations to access enhanced treatment options, which might otherwise be overlooked. To harness this potential, we trained a Deep Learning classifier on a large dataset with the ground truth for microsatellite status and subsequently validated its capabilities for MSI and POLE detection across three external cohorts. Our model accurately identified MSI status in both the internal and external resection cohorts using pathology images alone. Notably, with a classification threshold of 0.5, over 75% of POLE driver mutant patients in the external resection cohorts were flagged as 'positive' by a DL system trained on MSI status. In a clinical setting, deploying this DL model as a preliminary screening tool could facilitate the efficient identification of clinically relevant MSI and POLE mutations in colorectal tumors, in one go.

---

Contributing Institute(s):

1. C070 Klinische Epidemiologie und Alternf. (C070)
2. NWG Digitale Biomarker in der Onkologie (C140)
3. Präventive Onkologie (C120)
4. DKTK HD zentral (HD01)

Research Program(s):

1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2024

---

Database coverage:
; ; ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---